AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Bioelectric Medicine Market Analysis and Forecast, 2019-2025 - Growing Geriatric Population Leads to Surge in Exigency of Bioelectric Medicine - ResearchAndMarkets.com

November 4, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 4, 2019--

The “Global Bioelectric Medicine Market: Focus on Product, 11 Countries’ Data, and Competitive Landscape - Analysis and Forecast, 2019-2025” report has been added to ResearchAndMarkets.com’s offering.

The global bioelectric medicine industry analysis projects the market to grow at a significant CAGR of 6.41% during the forecast period, 2019-2025. The bioelectric medicine market generated $18,636.4 million revenue in 2018.

The bioelectric medicine growth has been primarily attributed to the major drivers such as growing geriatric population leads to surge in exigency of bioelectric medicine, increasing burden of diseases inciting the use of bioelectric medicine, growing investments and funds for the development of novel therapeutics and electroceuticals, limited success rate of drugs targeting specific disease, increasing amount of adverse drug reaction, and upsurge in awareness level.

The market is expected to grow at a significant growth rate due to the opportunities that lie within its domain, which include growth in emerging countries and technological advancement in bioelectric medicine. However, there are significant challenges which are restraining the market growth. These challenges include product recall, exorbitant cost of electroceuticals, increased regulatory scrutiny, and complications and side effects associated with the bioelectric medicine devices.

The pacemaker represents the biggest opportunity in the bioelectric medicine market, as the demand of pacemaker and awareness of about the pacemakers are higher compare to other bioelectric medicine products. The upsurge prevalence of cardiovascular diseases and the growing geriatric population has made it the largest sources of bioelectric medicine for the treatment of cardiovascular disorders.

Key Questions Answered in this Report:

Key Topics Covered:

Executive Summary

1 Product Definition

2 Scope of Work

2.1 Overview: Report Scope

2.2 Segmentation of the Global Bioelectric Medicine Market

2.3 Assumptions and Limitations

2.4 Key Questions Answered in the Report:

2.5 Base Year and Forecast Period

3 Research Methodology

3.1 Overview: Research Methodology

4 Industry Analysis

4.1 Regulatory Scenario

4.1.1 Legal Requirements and Regulations

4.1.1.1 Regulations in the U.S.

4.1.1.2 Regulations in Europe

4.1.1.3 Regulations in Other Countries

4.2 Patent Analysis

4.3 Product Pipeline

5 Competitive Landscape

5.1 Overview

5.2 Key Strategies and Development (2016-2019)

5.2.1 Product Launches, Approvals, and Clearances

5.2.2 Joint Venture, Agreement, Collaborations, and Partnerships

5.2.3 Mergers and Acquisitions

5.2.4 Business Expansion

5.3 Market Share Analysis of Spinal Cord Stimulation Devices in the Global Bioelectric Medicine Market

5.4 Market Share Analysis of Cochlear Implant in the Global Bioelectric Medicine Market

5.5 Market Share Analysis of Pacemaker and ICD in the Global Bioelectric Medicine Market

5.6 Growth Share Analysis

6 Evolution of Bioelectric Medicine

6.1 Evolution of the Pacemaker

6.2 Enabling Technologies Evolving Pacemaker and ICD

6.3 Evolution of the Neurostimulation Therapy

6.4 Enabling Technologies Evolving Neurostimulation Therapies

7 Global Bioelectric Medicine Market, 2018-2025

7.1 Assumptions and Limitations

7.2 Global Market Scenario

7.3 Market Dynamics

7.3.1 Overview

7.3.2 Impact Analysis

7.3.3 Market Drivers

7.3.3.1 Growing Geriatric Population Leads to Surge in Exigency of Bioelectric Medicine

7.3.3.2 Increasing Burden of Disease Inciting the Use of Bioelectric Medicine

7.3.3.2.1 Increasing Prevalence of Neurological Disorders

7.3.3.2.2 Increasing Prevalence of Hearing Loss

7.3.3.2.3 Increasing Prevalence of Cardiovascular Disorders

7.3.3.2.4 Increasing Burden of Blindness

7.3.3.3 Growing Investments and Funds for the Development of Novel Therapies and Electroceuticals

7.3.3.4 Limited Success Rate of Drugs Targeting Specific Disease

7.3.3.5 Increasing Amount of Adverse Drug Reaction

7.3.3.6 Upsurge in Awareness Level

7.3.4 Market Restraints

7.3.4.1 Product Recall

7.3.4.2 Exorbitant Cost of Electroceuticals

7.3.4.3 Increased Regulatory Scrutiny

7.3.4.4 Complications and Side-Effects Associated with the Bioelectric Medicine Devices

7.3.5 Market Opportunities

7.3.5.1 Growth in Emerging Countries

7.3.5.2 Technological Advancement in Bioelectric Medicine

7.3.5.2.1 Development of Closed Loop Neuromodulation

7.3.5.2.2 Evolution of Biomarker-Based Therapeutics Enabling Early Diagnostics of Neurological Disorders

7.3.5.2.3 Technological Advancement in Pacemakers

7.3.5.2.4 Technological Advancement in ICDs

8 Global Bioelectric Medicine Market by Product Type, 2018-2025

8.1 Overview

8.2 Competitive Benchmarking

8.3 Implantable Bioelectric Medicine

8.3.1 Cardiac Pacemaker

8.3.2 Implantable Cardioverter Defibrillators (ICD)

8.3.3 Spinal Cord Stimulation Device

8.3.4 Cochlear Implants

8.3.5 Deep Brain Stimulation Device

8.3.6 Vagus Nerve Stimulation Device

8.3.7 Others

8.4 Non-Implantable Bioelectric Medicine

9 Global Bioelectric Medicine Market (by Region)

10 Company Profiles

10.1 Overview

10.2 Abbott Laboratories

10.2.1 Company Overview

10.2.2 Financials

10.2.3 Role of Abbott Laboratories in the Bioelectric Medicines Market

10.2.4 SWOT Analysis

10.3 Boston Scientific Corporation

10.4 BIOTRONIK SE & Co. KG

10.5 Cochlear Limited

10.6 electroCore, Inc.

10.7 Inspire Medical Systems, Inc.

10.8 LivaNova Plc

10.9 Medtronic Plc

10.10 MED-EL

10.11 Nevro Corp.

10.12 Nuvectra Corporation

10.13 NeuroMetrix, Inc

10.14 Omron Corp

10.15 Pixium Vision

10.16 Second Sight Medical Products, Inc.

10.17 SetPoint Medical

10.18 Stimwave LLC

For more information about this report visit https://www.researchandmarkets.com/r/jtrw2r

View source version on businesswire.com:https://www.businesswire.com/news/home/20191104005375/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/04/2019 05:51 AM/DISC: 11/04/2019 05:51 AM

http://www.businesswire.com/news/home/20191104005375/en